Topolcan O - Search Results

1

Prognostic Significance of Serum Tumor Markers in Patients with Advanced-stage NSCLC Treated with Pemetrexed-based Chemotherapy.

Fiala O, Pesek M, Finek J, Svaton M, Sorejs O, Bortlicek Z, Kucera R, Topolcan O. Fiala O, et al. Among authors: topolcan o. Anticancer Res. 2016 Jan;36(1):461-6. Anticancer Res. 2016. PMID: 26722082

2

Circulating nucleosomes and cytokeratin 19-fragments in patients with colorectal cancer during chemotherapy.

Holdenrieder S, Holubec L Jr, Topolcan O, Finek J, Stieber P. Holdenrieder S, et al. Among authors: topolcan o. Anticancer Res. 2005 May-Jun;25(3A):1795-801. Anticancer Res. 2005. PMID: 16033102 Free article.

3

Quantitative estimation of CEA and CK20 expression in tumour tissue of colorectal cancer and its liver metastases with reverse transcription and real-time PCR.

Cerna M, Holubec L Jr, Pesta M, Kormunda S, Topolcan O, Cerny R. Cerna M, et al. Among authors: topolcan o. Anticancer Res. 2006 Jan-Feb;26(1B):803-8. Anticancer Res. 2006. PMID: 16739357 Free article.

4

Changes of serum thymidine kinase in children with acute leukemia.

Votava T, Topolcan O, Holubec L Jr, Cerna Z, Sasek L, Finek J, Kormunda S. Votava T, et al. Among authors: topolcan o. Anticancer Res. 2007 Jul-Aug;27(4A):1925-8. Anticancer Res. 2007. PMID: 17649797 Free article.

5

Test of ovarian cancer multiplex xMAP technology panel.

Vrzalova J, Prazakova M, Novotny Z, Topolcan O, Casova M, Holubec L Jr. Vrzalova J, et al. Among authors: topolcan o. Anticancer Res. 2009 Feb;29(2):573-6. Anticancer Res. 2009. PMID: 19331205 Free article.

6

Predictive value of serum biomarkers in patients after portal vein embolization (PVE): a pilot study.

Treska V, Topolcan O, Vrzalova J, Skalicky T, Sutnar A, Liska V, Fichtl J, Narsanska A, Ferda J, Treskova I, Mirka H, Kreuzberg B. Treska V, et al. Among authors: topolcan o. Anticancer Res. 2011 Jan;31(1):339-44. Anticancer Res. 2011. PMID: 21273621

7

Parameters of biological activity in colorectal cancer.

Svobodova S, Topolcan O, Holubec L Jr, Levy M, Pecen L, Svacina S. Svobodova S, et al. Among authors: topolcan o. Anticancer Res. 2011 Jan;31(1):373-8. Anticancer Res. 2011. PMID: 21273626

8

Evaluation of tumour markers as differential diagnostic tool in patients with suspicion of liver metastases from breast cancer.

Liska V, Holubec L Jr, Treska V, Vrzalova J, Skalicky T, Sutnar A, Kormunda S, Bruha J, Vycital O, Finek J, Pesta M, Pecen L, Topolcan O. Liska V, et al. Among authors: topolcan o. Anticancer Res. 2011 Apr;31(4):1447-51. Anticancer Res. 2011. PMID: 21508401

9

The role of MonoTotal in the primary diagnosis, prognosis and follow-up of patients with non-small cell lung cancer (NSCLC).

Prazakova M, Vrzalova J, Auge JM, Safranek J, Topolcan O, Fuchsova R, Spisakova M, Svobodova S, Holubec L Jr, Pesta M. Prazakova M, et al. Among authors: topolcan o. Anticancer Res. 2011 Sep;31(9):3107-12. Anticancer Res. 2011. PMID: 21868567

10

Vitamin D in colorectal, breast, prostate and lung cancer: a pilot study.

Pazdiora P, Svobodova S, Fuchsova R, Kucera R, Prazakova M, Vrzalova J, Narsanska A, Strakova M, Treskova I, Pecen L, Treska V, Holubec L Jr, Pesek M, Finek J, Topolcan O. Pazdiora P, et al. Among authors: topolcan o. Anticancer Res. 2011 Oct;31(10):3619-21. Anticancer Res. 2011. PMID: 21965787

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

292 results

Search Page

Filters